recombinant human-murine chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology)

N/A

Report date: 2025/03/20 10:10:33

Base Information

Drug Namerecombinant human-murine chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsEsophageal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Xinweishengke Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Xinweishengke Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsEsophageal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A